Unmet Needs for the Management of Depression

10.4103/TPSY.TPSY_25_19

Yi-Ju Pan

台灣精神醫學

33卷3期（2019 / 09 / 01）

122 - 124

英文

1. Chen, CY,Chiu, YH,Shen, WW(2018).Drug augmentation for treatment-refractory major depressive disorder.Taiwan J Psychiatry,32,188-199.
   連結：
2. Dunner, DL(2013).Treatment-resistant depression.Taiwan J Psychiatry,27,110-120.
   連結：
3. American Psychiatric Association(2010).Practice Guideline for the Treatment of Patients with Major Depressive Disorder.Arlington, Virginia, USA:American Psychiatric Association.
4. Anderson, IM(2018).We all know what we mean by treatment-resistant depression – Don’t we?.Br J Psychiatry,212,259-261.
5. Ballenger, JC(1999).Clinical guidelines for establishing remission in patients with depression and anxiety.J Clin Psychiatry,60(Suppl 16),29-34.
6. Baune, BT,Christensen, MC(2019).Differences in perceptions of major depressive disorder symptoms and treatment priorities between patients and health care providers across the acute, post-acute, and remission phases of depression.Front Psychiatry,10,335.
7. Chang, SM,Hahm, BJ,Lee, JY(2008).Cross-national difference in the prevalence of depression caused by the diagnostic threshold.J Affect Disord,106,159-167.
8. Compton, WM, 3rd,Helzer, JE,Hwu, HG(1991).New methods in cross-cultural psychiatry: psychiatric illness in Taiwan and the United States.Am J Psychiatry,148,1697-1704.
9. Empana, JP,Sykes, DH,Luc, G(2005).Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the prospective epidemiological study of myocardial infarction (PRIME).Circulation,111,2299-2305.
10. Greden, JF(2013).Workplace depression: personalize, partner, or pay the price.Am J Psychiatry,170,578-581.
11. Hwu, HG,Chang, IH,Yeh, EK(1996).Major depressive disorder in Taiwan defined by the Chinese diagnostic interview schedule.J Nerv Ment Dis,184,497-502.
12. Ickovics, JR,Hamburger, ME,Vlahov, D(2001).Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiology research study.JAMA,285,1466-1474.
13. Judd, LL,Paulus, MJ,Schettler, PJ(2000).Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?.Am J Psychiatry,157,1501-1504.
14. Kessler, RC,Berglund, P,Demler, O(2003).The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R).JAMA,289,3095-3105.
15. Lee, S,Tsang, A,Zhang, MY(2007).Lifetime prevalence and inter-cohort variation in DSM-IV disorders in metropolitan China.Psychol Med,37,61-71.
16. Liao, SC,Chen, WJ,Lee, MB(2012).Low prevalence of major depressive disorder in Taiwanese adults: possible explanations and implications.Psychol Med,42,1227-1237.
17. McAllister-Williams, RH,Christmas, DM,Cleare, AJ(2018).Multiple-therapy-resistant major depressive disorder: a clinically important concept.Br J Psychiatry,212,274-278.
18. Mojtabai, R,Olfson, M,Sampson, NA(2011).Barriers to mental health treatment: results from the national comorbidity survey replication.Psychol Med,41,1751-1761.
19. Naganuma, Y,Tachimori, H,Kawakami, N(2006).Twelve-month use of mental health services in four areas in Jaapan: findings from the world mental health Japan survey 2002-2003.Psychiatry Clin Neurosci,60,240-248.
20. Pan, YJ,Knapp, M,McCrone, P(2014).Impact of initial treatment outcome on long-term costs of depression: a 3-year nationwide follow-up study in Taiwan.Psychol Med,44,1147-1158.
21. Pan, YJ,Liu, SK,Yeh, LL(2013).Factors affecting early attrition and later treatment course of antidepressant treatment of depression in naturalistic settings: an 18-month nationwide population-based study.J Psychiatr Res,47,916-925.
22. Rush, AJ,Trivedi, MH,Wisniewski, SR(2006).Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.Am J Psychiatry,163,1905-1917.
23. Sheehan, DV,Nakagome, K,Asami, Y(2017).Restoring function in major depressive disorder: a systematic review.J Affect Disord,215,299-313.
24. Simon, GE,Goldberg, DP,Von Korff, M(2002).Understanding cross-national differences in depression prevalence.Psychol Med,32,585-594.
25. Thase, ME(2010).Unmet needs in the management of major depressive disorder.CNS Spectr,15,4-7.
26. Trivedi, MH,Rush, AJ,Wisniewski, SR(2006).Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.Am J Psychiatry,163,28-40.
27. Weissman, MM,Bland, RC,Canino, GJ(1996).Cross-national epidemiology of major depression and bipolar disorder.JAMA,276,293-299.
28. Zimmerman, M,McGlinchey, JB,Posternak, MA(2006).How should remission from depression be defined? the depressed patient’s perspective.Am J Psychiatry,163,148-150.